Actinium Pharmaceuticals, Inc. — Director's Dealing 2016

Apr 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-04-14

Reporting Person: Steinhart Richard I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-14	Common Stock	P	2500	$2.01	Acquired	2500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-15	Options to purchase common stock	$1.99	A	75000	Acquired	2026-04-15	Common Stock (75000)	Direct

Footnotes

F1: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.